We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Group A Streptococcus Rapid Immunoassay Evaluated

By LabMedica International staff writers
Posted on 27 Apr 2016
Clinical reasoning utilizing certain symptoms and scores has not proven to be a reliable decision-making tool to determine whether or not to suspect a group A Streptococcus (GAS) infection in the patient presenting with a sore throat.

An excellent solution for this dilemma would be a bedside rapid antigen detection test (RADT) for GAS that provides a positive or negative result within five to 10 minutes, thus directly influencing the treatment decision. More...
Such RADTs have been evaluated previously using throat culture as the gold standard and initially showed insufficient sensitivity and specificity.

Scientists at North West Hospital and Health Service (Mount Isa, QLD, Australia) collected throat swab samples from patients attending the Mount Isa Hospital emergency department for a sore throat; these samples were compared to swab samples collected from healthy controls that did not have a sore throat and both groups were aged three to 15 years. None of these children had previously had rheumatic fever.

The study team processed the swabs within 72 hours using the Alere Test Pack +Plus with OBC Strep A kit (Alere, Waltham, MA, USA). This test kit had shown a 95% to 97% sensitivity and a specificity of 95% to 100% to detect GAS. In this study the outcomes were compared with the assumption that the sensitivity of the point-of-care test was 95% and with the assumption that the sensitivity was 97%. The treating clinician was blinded to the point-of-care test result.

From June 30, 2014 to February 27, 2015, 248 throat swabs were collected and examined within 72 hours. Out of the 101 patients presenting with a sore throat, 26 (26%) tested positive for GAS. Only one (0.7%) of the 147 control patients had a positive test result. Statistical analysis showed both the positive and negative etiologic predictive value (EPV) to be high. The 95% confidence interval for positive EPV was 88% to 100% and for negative EPV was 97% to 99%, depending on assumptions made.

The authors concluded that their study demonstrated that the point-of-care test Alere Test Pack +Plus Strep A has a high positive predictive value and was able to rule in GAS infection as long as the proportion of carriers is low. Also the negative predictive value for ruling out GAS as the etiologic agent is very high irrespective of the carrier rate. Hence, this test is always useful to rule out GAS infection. The study was published in the April 2016 issue of the International Journal of Infectious Diseases.

Related Links:
North West Hospital and Health Service
Alere

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
HPV Test
Allplex HPV28 Detection
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer

Medullary thyroid cancer (MTC) is a rare malignancy that often progresses silently, frequently going undetected until it reaches advanced stages. By the time it spreads to bone, it can produce unusual... Read more

Molecular Diagnostics

view channel
Image: In the Fetal Extracellular Vesicle Monitoring of Oxygenation (FEMOx) project several of the Wyss Institute’s Technology Platforms and faculty labs join forces. Leveraging and integrating multiple of the Wyss Institute’s technological innovations and advanced analytical capabilities they aim develop a test that can rapidly and accurately detect fetal oxygen deprivation by detecting specific miRNA signatures in extracellular vesicles (EVs) that circulate in maternal blood. (Iimage Credit: Wyss Institute at Harvard University)

Project to Develop Maternal Blood Test for Rapid Fetal Oxygen Deprivation Detection

Intrapartum fetal hypoxia remains difficult to assess with existing monitoring, leaving clinicians to make time-critical decisions with incomplete data. Limited detection and interpretation can contribute... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.